These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 21189326)

  • 1. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.
    Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA
    Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.
    Sterling JA; Oyajobi BO; Grubbs B; Padalecki SS; Munoz SA; Gupta A; Story B; Zhao M; Mundy GR
    Cancer Res; 2006 Aug; 66(15):7548-53. PubMed ID: 16885353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
    Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II.
    Page JM; Merkel AR; Ruppender NS; Guo R; Dadwal UC; Cannonier S; Basu S; Guelcher SA; Sterling JA
    Biomaterials; 2015 Sep; 64():33-44. PubMed ID: 26115412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma.
    Cannonier SA; Gonzales CB; Ely K; Guelcher SA; Sterling JA
    Oncotarget; 2016 Nov; 7(46):76062-76075. PubMed ID: 27738315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo.
    Dennler S; André J; Alexaki I; Li A; Magnaldo T; ten Dijke P; Wang XJ; Verrecchia F; Mauviel A
    Cancer Res; 2007 Jul; 67(14):6981-6. PubMed ID: 17638910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis.
    Javelaud D; Alexaki VI; Dennler S; Mohammad KS; Guise TA; Mauviel A
    Cancer Res; 2011 Sep; 71(17):5606-10. PubMed ID: 21862631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.
    Yin JJ; Selander K; Chirgwin JM; Dallas M; Grubbs BG; Wieser R; Massagué J; Mundy GR; Guise TA
    J Clin Invest; 1999 Jan; 103(2):197-206. PubMed ID: 9916131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone-related protein and bone metastases.
    Guise TA
    Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis.
    Wright LE; Frye JB; Lukefahr AL; Timmermann BN; Mohammad KS; Guise TA; Funk JL
    J Nat Prod; 2013 Mar; 76(3):316-21. PubMed ID: 23145932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.
    Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA
    Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
    Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
    J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLI2-mediated melanoma invasion and metastasis.
    Alexaki VI; Javelaud D; Van Kempen LC; Mohammad KS; Dennler S; Luciani F; Hoek KS; Juàrez P; Goydos JS; Fournier PJ; Sibon C; Bertolotto C; Verrecchia F; Saule S; Delmas V; Ballotti R; Larue L; Saiag P; Guise TA; Mauviel A
    J Natl Cancer Inst; 2010 Aug; 102(15):1148-59. PubMed ID: 20660365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
    Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Thioguanine inhibition of parathyroid hormone-related protein expression is mediated by GLI2.
    Johnson RW; Merkel AR; Danilin S; Nguyen MP; Mundy GR; Sterling JA
    Anticancer Res; 2011 Sep; 31(9):2705-12. PubMed ID: 21868511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA; Chirgwin JM
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways.
    Kakonen SM; Selander KS; Chirgwin JM; Yin JJ; Burns S; Rankin WA; Grubbs BG; Dallas M; Cui Y; Guise TA
    J Biol Chem; 2002 Jul; 277(27):24571-8. PubMed ID: 11964407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts.
    Jun AY; Kim HJ; Park KK; Son KH; Lee DH; Woo MH; Chung WY
    Invest New Drugs; 2014 Feb; 32(1):1-13. PubMed ID: 23673814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
    J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.